CompletedPhase 4

Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.

Sweden44 participantsStarted 2019-04-10

Plain-language summary

This study evaluates the effect of intramuscular injected methylprednisolone treating birch pollen induced rhinitis compared to placebo.

Who can participate

Age range

18 Years – 55 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Severe birch pollen induced allergic rhinitis. * Signed informed consent according to International Council of Harmonisation/Good Clinical Practice, and national/local regulations. * Women of considered childbearing potential (WOCBP) will only be included after a negative highly sensitive pregnancy test according to CTFG recommendations. Exclusion Criteria: * Pregnancy or nursing. * Autoimmune or collagen disease. * Cardiovascular disease. * Hepatic disease. * Renal disease. * Cancer. * Upper airway disease (non-allergic sinusitis, nasal polyposis, chronic obstructive- and restrictive lung disease). * Medication with a possible side-effect of interfering with the immune response. * Previous immuno- or chemotherapy. * Chronic disease. * Major metabolic disease. * Alcohol or drug abuse. * Mental incapability of coping with the study. * Known or suspected allergy to the study product. * Suspicion of or confirmed bacterial infection. * Known allergy to the study drugs, "rescue medication".

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Mean Combined Medical- and Symptom score (CSMS)

Timeframe: 3 weeks

Mean symptom score

Timeframe: 3 weeks

Trial details

NCT IDNCT04622917

SponsorKarolinska Institutet

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-06-20

View on ClinicalTrials.gov More Rhinitis, Allergic, Seasonal trials

Who can participate

Age range

18 Years – 55 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.